Literature DB >> 33625636

The SMART-ALPPS Protocol: Strategy to Minimize ALPPS Risks by Targeting Invasiveness.

G Fiorentini1,2, F Ratti3, F Cipriani3, R Quattromani3, M Catena3, M Paganelli3, L Aldrighetti3,4.   

Abstract

BACKGROUND: The range of procedures with documented feasibility by laparoscopic approach is widening in the setting of liver resections. Many technical limits have been overcome in the attempt to reduce the biological impact of major procedures [1-8]. Similarly, associated liver partition and portal vein ligation for staged hepatectomy (ALPPS)-which could be assumed as the paradigm of maxi-invasiveness-has recently been proposed in a minimally invasive fashion to reduce the impact of this procedure [9-12]. Technical insights to perform laparoscopic ALPPS are provided.
METHODS: Perioperative and intraoperative tips for laparoscopic ALPPS are provided within a SMART (Strategy to Minimize ALPPS Risks by Targeting invasiveness) protocol. Stage 1: After volumetric and functional assessment, partial liver transection is performed, keeping intact both the hilum and the caval plane (to prevent adhesions), therefore avoiding portal ligation. No inert material is left inside the abdominal cavity at the end of procedure to keep the liver surfaces apart. Radiologic portography with portal vein embolization is scheduled on postoperative day (POD) 1. Liver volume (pre-PVE: 29%; post-PVE: 52%) and liver function measured through a Technetium-99 hepatobiliary scintigraphy [13] (pre-PVE: 2.15%/min/sqm; post-PVE: 3.67%/min/sqm) of the future remnant liver are reassessed within 10 days to verify whether size and function are adequate. Stage 2: After 2 weeks from the first stage, laparoscopic right hepatectomy is performed following an anterior approach.
RESULTS: No conversion to open was required. Operative time was 100 and 300 minutes for stage 1 and 2, respectively. Intraoperative blood loss was 50 and 300 ml for the two procedures. Postoperative course was uneventful; patient was discharged on POD 6 of the second operation.
CONCLUSIONS: The implementation of a perioperative protocol to prevent the risk of liver failure by both assessing volume and function of FLR and targeting the invasiveness of the surgical procedure may allow to minimize and control risks of a maximally invasive procedure, such as ALPPS.

Entities:  

Year:  2021        PMID: 33625636     DOI: 10.1245/s10434-021-09711-7

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  9 in total

Review 1.  Laparoscopic Liver Resection: A Review of Current Status.

Authors:  Yihe Yan; Xiaoyong Cai; David A Geller
Journal:  J Laparoendosc Adv Surg Tech A       Date:  2017-02-13       Impact factor: 1.878

2.  Theory of Relativity for Posterosuperior Segments of the Liver.

Authors:  G Fiorentini; F Ratti; F Cipriani; L Cinelli; M Catena; M Paganelli; L Aldrighetti
Journal:  Ann Surg Oncol       Date:  2019-01-23       Impact factor: 5.344

3.  Measurement of liver function using hepatobiliary scintigraphy improves risk assessment in patients undergoing major liver resection.

Authors:  Kasia P Cieslak; Roelof J Bennink; Wilmar de Graaf; Krijn P van Lienden; Marc G Besselink; Olivier R C Busch; Dirk J Gouma; Thomas M van Gulik
Journal:  HPB (Oxford)       Date:  2016-07-25       Impact factor: 3.647

4.  Tips and Tricks for a Laparoscopic Approach to Paracaval Liver Segments.

Authors:  G Fiorentini; F Ratti; F Cipriani; M Catena; M Paganelli; L Aldrighetti
Journal:  Ann Surg Oncol       Date:  2018-03-29       Impact factor: 5.344

5.  Minimally Invasive Approach in the Setting of ALPPS Procedure: a Systematic Review of the Literature.

Authors:  Fabio Melandro; Francesco Giovanardi; Redan Hassan; Zoe Larghi Laureiro; Flaminia Ferri; Massimo Rossi; Gianluca Mennini; Timothy M Pawlik; Quirino Lai
Journal:  J Gastrointest Surg       Date:  2019-06-13       Impact factor: 3.452

6.  Minimally Invasive Stage 1 to Protect Against the Risk of Liver Failure: Results from the Hepatocellular Carcinoma Series of the Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy Italian Registry.

Authors:  Matteo Serenari; Francesca Ratti; Matteo Zanello; Nicola Guglielmo; Federico Mocchegiani; Fabrizio Di Benedetto; Bruno Nardo; Vincenzo Mazzaferro; Umberto Cillo; Marco Massani; Michele Colledan; Raffaele Dalla Valle; Matteo Cescon; Marco Vivarelli; Marco Colasanti; Giuseppe Maria Ettorre; Luca Aldrighetti; Elio Jovine
Journal:  J Laparoendosc Adv Surg Tech A       Date:  2020-09-09       Impact factor: 1.878

7.  Tumor Necrosis Impacts Prognosis of Patients Undergoing Curative-Intent Hepatocellular Carcinoma.

Authors:  Tao Wei; Xu-Feng Zhang; Fabio Bagante; Francesca Ratti; Hugo P Marques; Silvia Silva; Olivier Soubrane; Vincent Lam; George A Poultsides; Irinel Popescu; Razvan Grigorie; Sorin Alexandrescu; Guillaume Martel; Aklile Workneh; Alfredo Guglielmi; Tom Hugh; Luca Aldrighetti; Itaru Endo; Timothy M Pawlik
Journal:  Ann Surg Oncol       Date:  2020-11-28       Impact factor: 5.344

8.  Challenges and Technical Innovations for an Effective Laparoscopic Lymphadenectomy in Liver Malignancies.

Authors:  Guido Fiorentini; Francesca Ratti; Federica Cipriani; Marco Catena; Michele Paganelli; Luca Aldrighetti
Journal:  J Laparoendosc Adv Surg Tech A       Date:  2018-10-27       Impact factor: 1.878

Review 9.  First quarter century of laparoscopic liver resection.

Authors:  Zenichi Morise; Go Wakabayashi
Journal:  World J Gastroenterol       Date:  2017-05-28       Impact factor: 5.742

  9 in total
  2 in total

1.  ASO Author Reflections: The SMART-ALPPS Protocol-Strategy to Minimize ALPPS Risks by Targeting Invasiveness.

Authors:  G Fiorentini; F Ratti; F Cipriani; L Aldrighetti
Journal:  Ann Surg Oncol       Date:  2021-03-31       Impact factor: 5.344

2.  Mechanism of Liver Regeneration During ALPPS.

Authors:  Yao Xiao; Lantao Peng; Hongjuan Xu; Ming Huang; Chao Yang; Guodong Liu; Xiwu Ouyang; Xiaoli Li; Yuanjing Wang; Langqing Sheng; Denggao Zhai; Ling Lin; Ling Liu; Gang Liu; Liansheng Gong
Journal:  Front Cell Dev Biol       Date:  2022-06-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.